These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35178370)

  • 1. Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment.
    Huang Y; Huang Q; Xu A; Lu M; Xi X
    Front Public Health; 2021; 9():782964. PubMed ID: 35178370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the Preferences and Willingness-to-Pay for Oral Antidiabetic Drugs Among Patients with Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment.
    Chuang LH; Zhang H; Hong T; Xie S
    Patient; 2024 Sep; 17(5):565-574. PubMed ID: 38642244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valuing injection frequency and other attributes of type 2 diabetes treatments in Australia: a discrete choice experiment.
    Fifer S; Rose J; Hamrosi KK; Swain D
    BMC Health Serv Res; 2018 Aug; 18(1):675. PubMed ID: 30165844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences for medication attributes among patients with type 2 diabetes mellitus in the UK.
    Gelhorn HL; Stringer SM; Brooks A; Thompson C; Monz BU; Boye KS; Hach T; Lund SS; Palencia R
    Diabetes Obes Metab; 2013 Sep; 15(9):802-9. PubMed ID: 23464623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willingness to pay for improvements in chronic long-acting insulin therapy in individuals with type 1 or type 2 diabetes mellitus.
    Lloyd A; Nafees B; Barnett AH; Heller S; Ploug UJ; Lammert M; Bøgelund M
    Clin Ther; 2011 Sep; 33(9):1258-67. PubMed ID: 21862132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding patient cost-sharing thresholds for diabetes treatment attributes via a discrete choice experiment.
    Panchal R; Nguyen D; Ghule P; Li N; Giannouchos T; Pan RJ; Biskupiak J; Britton L; Nohavec R; Slager S; Ngorsuraches S; Brixner D
    J Manag Care Spec Pharm; 2023 Feb; 29(2):139-150. PubMed ID: 36705280
    [No Abstract]   [Full Text] [Related]  

  • 7. Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes.
    Jendle J; Torffvit O; Ridderstråle M; Lammert M; Ericsson A; Bøgelund M
    Curr Med Res Opin; 2010 Apr; 26(4):917-23. PubMed ID: 20163195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferences for Patients with Type 2 Diabetes Mellitus for Medications in Shandong Province, China: A Discrete Choice Experiment.
    Lv Y; Ren R; Tang C; Song K; Li S; Wang H
    Patient Prefer Adherence; 2022; 16():2335-2344. PubMed ID: 36046499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating Preferences of Hospitalized Diabetes Patients for Hospital-Wide Glycemic Control Programme: A Discrete Choice Experiment.
    Dai J; He T; He X; Li H; Li L; Sun J; Pan J; Ji C
    J Diabetes Res; 2024; 2024():2552658. PubMed ID: 39280993
    [No Abstract]   [Full Text] [Related]  

  • 10. What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences.
    Mühlbacher A; Bethge S
    Eur J Health Econ; 2016 Dec; 17(9):1125-1140. PubMed ID: 26682548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A discrete choice experiment to understand preferences of patients with type 2 diabetes treated with injectable non-insulinic agents.
    Darbà J; Ascanio M
    Curr Med Res Opin; 2021 Jan; 37(1):37-43. PubMed ID: 33269944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoidance of weight gain is important for oral type 2 diabetes treatments in Sweden and Germany: patient preferences.
    Mohamed AF; Zhang J; Johnson FR; Lomon ID; Malvolti E; Townsend R; Ostgren CJ; Parhofer KG
    Diabetes Metab; 2013 Oct; 39(5):397-403. PubMed ID: 23880594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socioeconomic differences in preferences and willingness-to-pay for insulin delivery systems in type 1 and type 2 diabetes.
    Guimarães C; Marra CA; Colley L; Gill S; Simpson S; Meneilly G; Queiroz RH; Lynd LD
    Diabetes Technol Ther; 2009 Sep; 11(9):567-73. PubMed ID: 19764835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 diabetes patients' preferences and willingness to pay for lifestyle programs: a discrete choice experiment.
    Veldwijk J; Lambooij MS; van Gils PF; Struijs JN; Smit HA; de Wit GA
    BMC Public Health; 2013 Nov; 13():1099. PubMed ID: 24289831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Patients with Type 1 and Type 2 Diabetes.
    Seo J; Heidenreich S; Aldalooj E; Poon JL; Spaepen E; Eby EL; Newson RS
    Patient; 2023 Mar; 16(2):127-138. PubMed ID: 36437389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized diabetes management: what do patients with diabetes mellitus prefer? A discrete choice experiment.
    Mühlbacher AC; Sadler A; Juhnke C
    Eur J Health Econ; 2021 Apr; 22(3):425-443. PubMed ID: 33587221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' and physicians' preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a discrete choice experiment.
    Morillas C; Feliciano R; Catalina PF; Ponte C; Botella M; Rodrigues J; Esmatjes E; Lafita J; Lizán L; Llorente I; Morales C; Navarro-Pérez J; Orozco-Beltran D; Paz S; Ramirez de Arellano A; Cardoso C; Tribaldos Causadias M
    Patient Prefer Adherence; 2015; 9():1443-58. PubMed ID: 26508841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient preferences for diabetes management among people with type 2 diabetes in Denmark - a discrete choice experiment.
    Bøgelund M; Vilsbøll T; Faber J; Henriksen JE; Gjesing RP; Lammert M
    Curr Med Res Opin; 2011 Nov; 27(11):2175-83. PubMed ID: 21981417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient preferences for anti-hyperglycaemic medication for type 2 diabetes mellitus in China: findings from a national survey.
    Liu S; Liu J; Si L; Ke X; Liu L; Ren Y; Bao S; Li F; Yu Y; Pan Q; Wei Y; Chen Y
    BMJ Glob Health; 2023 Apr; 8(4):. PubMed ID: 37041021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urban-rural differences in preferences for traditional Chinese medicine services among chronic disease patients: a discrete choice experiment.
    Jiang F; Feng Y; Zong W; Xue J; Chen W; Qizhi L; Zhang J; Xu A
    BMC Complement Med Ther; 2024 Oct; 24(1):369. PubMed ID: 39402534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.